J&J restoring cancer drug supply to EU patients
A subsidiary of German drugmaker Boehringer Ingelheim, Ben Venue said on Oct. 16 it had resume limiting manufacturing at the Ohio plant, where it's investing more than $300 million in upgrades. Still, most products it makes there won't be available for several more months.
The Ben Venue supply problem comes amid more than three dozen recalls by Johnson & Johnson since September 2009 for products it manufactures, from Tylenol and other nonprescription drugs to prescription medicines, contact lenses and defective hip implants.
Among the most recent recalls is one from August — just announced recently — involving three brands of staplers used in hemorrhoid and rectal surgery. According to the FDA, the devices can misfire, causing incomplete staple formation that can result in death, severe pain, bleeding, infection and damage to or blockage of the rectal canal.
Linda A. Johnson can be followed at http://twitter.com/LindaJ_onPharma
News Photo Galleriesview all
- 14589OKC Thunder: Thunder trio praise fans before potential departures
- 8609Oklahoma State football: Todd Monken thinks Wes Lunt should've stayed in Stillwater
- 6402Student shot dead during botched home invasion
- 6393Oklahoma medical examiner reports cause of deaths in Grand Lake boat crash
- 6018Soaring gasoline prices hurt Oklahoma City area retailers
- 5816Oklahoma football: Sooners get pair of commitments
- 4098As Boy Scouts' vote on gay members nears, faith groups weigh in